(1 - 13 von 14
)
Exelixis files IND for anti-cancer drug - UPI.com
www.upi.com
Exelixis said Friday it submitted an investigational new drug application to the Food and Drug Administration for its new cancer treatment.
UPDATE 3-Biogen names Exelixis' Scangos CEO | Reuters
www.reuters.com
Biogen names George Scangos new CEO. * Scangos previously CEO of Exelixis Inc. * Scangos takes over from retired Jim Mullen. * Biogen ...
Biogen Idec ernennt George Scangos zum CEO
www.finanznachrichten.de
Exelixis-CEO und ehemaliger Vorsitzender der Biotechnologiesparte von Bayer bringt starke wissenschaftliche Kompetenz und weitreichende Erfahrung in der Biotech- und Pharmabranche
George Scangos Biography - Harvard Business School
www.hbs.edu
George Scangos Biography George A. Scangos, Ph.D. was appointed Chief Executive Officer and a member of the Board of Directors of Biogen Idec in June He joined the company from Exelixis, Inc., where he served as President and CEO and a director since October From September to October 1996, Dr. Scangos served as
sortiert nach Relevanz / Datum